Immune escape mechanisms and therapeutic advances in virus-associated hematological malignancies. [PDF]
Li T +6 more
europepmc +1 more source
FC-duplex IgG1 (HTLV-1/2): Qualifying the flow cytometry IgG1 duplex assay for differential diagnosis of HTLV-1 and HTLV-2 infections. [PDF]
Martins JP +14 more
europepmc +1 more source
Clinical outcomes-dependent IgG epitope profiling in HTLV-1 reveals differential recognition of pathogen-derived antigens. [PDF]
Cilento NE +9 more
europepmc +1 more source
Morbidity and Mortality Among People Living With HTLV-1: A 30-Year Retrospective Analysis in a Brazilian Cohort. [PDF]
Neves ES +10 more
europepmc +1 more source
The KT Jeang retrovirology prize 2025: Carine Van Lint. [PDF]
Van Lint C.
europepmc +1 more source
Targeting PRMT5 in Adult T-Cell Leukemia/Lymphoma: Opportunities and Challenges. [PDF]
Ernzen K, Panfil AR.
europepmc +1 more source
Dolutegravir use is related to lower HTLV-1 proviral load in people co-infected by HIV-1. [PDF]
Fernandez T +4 more
europepmc +1 more source
[HTLV-I AND HTLV-II in Spain].
Up to October 1994, twenty-four HTLV-I and 113 HTLV-II infected persons have been identified in Spain. A third of HTLV-I carriers were immigrants coming from endemic regions. In contrast, most HTLV-II-infected persons were Spanish native drug users. Four cases of HTLV-I-associated myelopathy (TSP) were found, and three patients suffered lymphoma (ATL).
openaire +1 more source
Antenatal Screening for HTLV-1 and -2 Among Pregnant Women in Grenada: Combined Seroprevalence, Trends, and Public Health Implications (2015-2024). [PDF]
Joseph SN +4 more
europepmc +1 more source

